Abstract
Abstract
Background: Accurate diagnosis of thyroid nodules is important for
avoiding unnecessary surgeries and allowing timely treatment. Ultrasound
and fine needle aspiration cytology (FNAC) are the most commonly used
diagnostic procedures.
Objective: To correlate ultrasonography with the FNAC report findings
using the American College of Radiology Thyroid Imaging Reporting and
Data System (ACR TI-RADS) and the Bethesda System for Reporting
Thyroid Cytopathology (TBSRTC) in differentiating malignant from
benign thyroid nodules.
Patients and Methods: A prospective study conducted from January 2021
to January 2024 assessed 103 cases of thyroid nodules who underwent
ultrasound examination and fine needle aspiration. Ultrasonography
findings were analyzed and correlated with FNA cytology reports based on
ACR-TIRADS and BSRTC.
Results: Patients were predominantly female, n = 87 (84.4%). Most of the patients
were in the 31–40 year group (n = 55, 53.39%). Most of the patient nodules had
TIRADS 3 (n = 59, 57.28%), followed by TIRADS 2 (n = 20, 18.44%). When
comparing the ACR TI-RADS scoring system with the TBSRTC, the percentage of
malignancy for TR1, 2, 3, 4, and 5 was 0, 0, 1.6, 80, and 89%, respectively. In our
study, the overall sensitivity and specificity of the TIRADS score were 94.11% and
96.51%, respectively. PPV: 84.21%; NPV: 98.80%; and accuracy: 96.11%. In
addition, there was a significant association between TIRADS and the Bethesda
system of classification (P < 0.001).
Conclusion: ACR-TIRADS scoring is highly sensitive and accurate for
diagnosing thyroid malignant nodules. It is a sensitive tool and could be
used alone to determine the nature of thyroid nodules.
Background: Accurate diagnosis of thyroid nodules is important for
avoiding unnecessary surgeries and allowing timely treatment. Ultrasound
and fine needle aspiration cytology (FNAC) are the most commonly used
diagnostic procedures.
Objective: To correlate ultrasonography with the FNAC report findings
using the American College of Radiology Thyroid Imaging Reporting and
Data System (ACR TI-RADS) and the Bethesda System for Reporting
Thyroid Cytopathology (TBSRTC) in differentiating malignant from
benign thyroid nodules.
Patients and Methods: A prospective study conducted from January 2021
to January 2024 assessed 103 cases of thyroid nodules who underwent
ultrasound examination and fine needle aspiration. Ultrasonography
findings were analyzed and correlated with FNA cytology reports based on
ACR-TIRADS and BSRTC.
Results: Patients were predominantly female, n = 87 (84.4%). Most of the patients
were in the 31–40 year group (n = 55, 53.39%). Most of the patient nodules had
TIRADS 3 (n = 59, 57.28%), followed by TIRADS 2 (n = 20, 18.44%). When
comparing the ACR TI-RADS scoring system with the TBSRTC, the percentage of
malignancy for TR1, 2, 3, 4, and 5 was 0, 0, 1.6, 80, and 89%, respectively. In our
study, the overall sensitivity and specificity of the TIRADS score were 94.11% and
96.51%, respectively. PPV: 84.21%; NPV: 98.80%; and accuracy: 96.11%. In
addition, there was a significant association between TIRADS and the Bethesda
system of classification (P < 0.001).
Conclusion: ACR-TIRADS scoring is highly sensitive and accurate for
diagnosing thyroid malignant nodules. It is a sensitive tool and could be
used alone to determine the nature of thyroid nodules.
Keywords
Thyroid malignancies
Ultrasonography
Yemen